NECTA Drug Development Meeting 2026
The NECTA Drug Development Meeting 2026 will be held on Friday, 27 March 2026, at the Garvan Institute of Medical Research in Sydney. This specialized forum focuses on critical shifts […]
The NECTA Drug Development Meeting 2026 will be held on Friday, 27 March 2026, at the Garvan Institute of Medical Research in Sydney. This specialized forum focuses on critical shifts […]
The Summit on Cancer Health Disparities (SCHD26) is a two-day conference organized by Binaytara, scheduled for March 27–28, 2026, at the Hyatt Regency Bellevue in Bellevue, Washington, United States. This […]
The 13th Belgian Multidisciplinary meeting on Urological Cancers (BMUC 2026) is a specialized oncology congress scheduled for Friday, March 27, and Saturday, March 28, 2026. Organized by the Belgian Multidisciplinary […]
The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled […]
The Emirates Digestive Diseases Week (EDDW) 2026 is the Middle East's premier educational platform for gastroenterology and hepatology. Scheduled for March 27–28, 2026, in Dubai, UAE, the 10th-anniversary edition will […]
The EASL Congress 2026, organized by the European Association for the Study of the Liver, is Europe's largest event dedicated to hepatology. It is scheduled to take place from May […]
The ALRCaN Global webinar, “Reliable leukemia subtyping with machine learning and conformal prediction?” is set for Friday, March 27, 2026, from 09:00 AM to 10:00 AM ET. Led by Mariya Lysenkova Wiklander, this session examines improving leukemia classification through advanced computational methods. Organized by ALRCaN Global and Resonance Health, and supported by Scott Howard, Stacy […]
The ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026 webinar, scheduled for April 1, 2026, focuses on the integration of precision diagnostics and […]
The ALRCaN Global webinar, “Newly diagnosed AML: 2026 Treatment algorithms” is set for Friday, April 03, 2026, from 09:00 AM to 10:00 AM ET. Led by Dr. Naseema Gangat, this session examines current treatment strategies and algorithms for acute myeloid leukemia. Organized by ALRCaN Global and Resonance Health, and supported by Scott Howard, Stacy Cooper, […]
The public meeting, "Application of External Control Arms in Oncology Drug Development," hosted by Friends of Cancer Research, is scheduled for Tuesday, April 7, 2026, from 10:00 AM to 2:00 […]
The SIOG 2026 Research Masterclass is an intensive, three-day course organized by the International Society of Geriatric Oncology (SIOG), running from April 8 to April 10, 2026. The event will […]
The International Conference on Assisted Dying and Other End-of-Life Care (ICEL5), hosted by the Australian Centre for Health Law Research, will take place from 8–11 April 2026 at the Queensland […]
The 2026 Texas Lung Cancer Conference (TLC 2026) is scheduled to take place from April 9 to 11, 2026, at ACL Live at The Moody Theater in Austin, Texas. This […]
The APPOS Tampa 2026: Advanced Practice Providers Oncology Summit will be held April 10–11, 2026, in Tampa, Florida, USA. This two-day conference is designed for advanced practice providers—including nurse practitioners, physician assistants, pharmacists, and oncology nurses—and focuses on evidence-based strategies for the multidisciplinary treatment and management of oncology patients. Attendees can earn continuing education (CE) […]
The 2026 Highlights of ASH in Asia-Pacific is a two-day program co-hosted by the American Society of Hematology (ASH) and the Malaysian Society of Hematology. The event is scheduled for April 10–11, 2026, in Kuala Lumpur, Malaysia, bringing together global hematology leaders to discuss the most influential and novel research presented at the latest ASH […]
The 23rd Annual International Ultmann Chicago Lymphoma Symposium (IUCLS) is scheduled for April 10–11, 2026, at the JW Marriott Chicago in Chicago, IL. This premier CME-accredited conference honors the legacy of Dr. John Ultmann by providing a specialized forum for oncologists, hematologists, and researchers to discuss the latest biologic and therapeutic advancements in Hodgkin and […]